Cargando…
Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma
BACKGROUND: Accumulating evidence has shown that long noncoding RNA (lncRNA) CRNDE functions as an oncogene in many cancer types. However, its clinical value has not yet been explored in hepatocellular carcinoma (HCC). METHODS: A total of 166 patients with HCC and 100 healthy volunteers were enrolle...
Autores principales: | Wang, Ting, Zhu, Hengkai, Xiao, Min, Zhou, Shao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605167/ https://www.ncbi.nlm.nih.gov/pubmed/34612554 http://dx.doi.org/10.1002/jcla.23959 |
Ejemplares similares
-
Serum exosomal long noncoding RNA CRNDE level for hepatocellular carcinoma diagnosis
por: Huang, Xiao‐Li, et al.
Publicado: (2021) -
Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer
por: Liu, Tong, et al.
Publicado: (2016) -
Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3‐Crnde negative feedback in diabetic cardiomyopathy
por: Zheng, Dezhi, et al.
Publicado: (2019) -
Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis
por: Zhou, Yu, et al.
Publicado: (2019) -
CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies
por: Ma, Xuefei, et al.
Publicado: (2022)